Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

NCT02429622 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms

Interventions

RADIATION: IMRT simultaneous integrated boost
DRUG: Paclitaxel
DRUG: Nedaplatin
PROCEDURE: Esophagectomy

Sponsor

Chinese Academy of Medical Sciences